Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
1
2014
FDA (Food and Drug Administration) Issues Long-Awaited Draft Guidance Documents Concerning Internet/Social Media Covington & Burling LLP
Jul
9
2014
Confronting Apocalyptic Risks of Broken Antibiotics Pipeline Covington & Burling LLP
Aug
11
2014
MHRA creates new expert advisory group on medical devices Covington & Burling LLP
Sep
20
2014
Court Rejects FDA’s Interpretation of the Statute’s Device Definition as “Erroneous and Unreasonable” Covington & Burling LLP
Oct
29
2014
Recent Trends in Medical Device Patent Litigation at the ITC — Part 1 Covington & Burling LLP
Nov
19
2014
Mirror, Mirror on Your App…The Cosmetics Industry Embraces Digital Covington & Burling LLP
Dec
19
2014
U.S. Commerce Department Prioritizes Mozambique in 2015 Covington & Burling LLP
Jan
20
2015
Giant Multinational Unilever Drops Suit Against Innovative Start-up Hampton Creek Over Eggless “Mayonnaise” Covington & Burling LLP
Jun
12
2015
New Draft EMA-Guideline On Clinical Development Of Fixed Combination Medicines Covington & Burling LLP
Sep
28
2015
FDA Proposes Amending the Definition of “Intended Use” Covington & Burling LLP
Jan
7
2016
CDRH Posts Planned Guidance Activity for FY 2016 Covington & Burling LLP
Aug
3
2017
FDA Initiates Software Precertification Pilot Program Covington & Burling LLP
Aug
8
2017
EU Policy Update, August 2017: Tech and Digital Single Market Policies; Communication and Media Policies; Energy and Environment Policies; Internal Market and Financial Services Policies; Life Sciences and Healthcare Covington & Burling LLP
May
17
2014
The European Commission Launches a Public Consultation on a EU Nano-Registry Covington & Burling LLP
Aug
19
2014
FDA Issues Final Guidance on "In Vitro Companion Diagnostic Devices" Covington & Burling LLP
Sep
9
2014
FTC Brings its First Post-Actavis Suit re: Pharmaceutical Patent Litigation Covington & Burling LLP
Sep
22
2014
Major Damages Award in Pelvic Mesh Case Underscores the Critical Role of Internal Email in Jury Trials Covington & Burling LLP
Feb
5
2015
President’s Budget Includes Funding for Precision Medicine Initiative Covington & Burling LLP
Feb
10
2015
Important Developments in FDA Regulation of Software, Including Mobile Apps Covington & Burling LLP
Apr
21
2015
FDA Issues Draft Guidance Concerning the Use of Electronic Informed Consent in Clinical Investigations Covington & Burling LLP
Dec
22
2015
Comprehensive Amendments of German Drug Laws upcoming Covington & Burling LLP
Aug
5
2016
FDA Finalizes General Wellness Guidance Covington & Burling LLP
Oct
17
2016
Italy’s AGCM Market Competition Authority Fines Aspen EUR 5 Million for Excessive Pricing Covington & Burling LLP
Dec
8
2016
UK Competition and Markets Authority Imposes Record Fine on Pfizer Covington & Burling LLP
Apr
30
2017
The Week Ahead in the European Parliament – April 28, 2017 Covington & Burling LLP
Jul
26
2017
Senate Armed Services Committee Directs DoD to Reduce Drug Prices Covington & Burling LLP
Aug
1
2017
The Congressional Agenda for August Covington & Burling LLP
Oct
9
2017
FDA Draft Guidance Addresses Medical Device Status of Microneedling Products Covington & Burling LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins